Regarding: "Hydroxychloroquine: a comprehensive review and its controversial role in coronavirus disease 2019".
作者信息
McCullough Peter A
机构信息
Texas A & M University, College of Medicine, Professor (Affiliated), Department of Internal Medicine, Baylor University Medical Center, Dallas, TX, USA.
出版信息
Ann Med. 2021 Dec;53(1):286. doi: 10.1080/07853890.2021.1872094.
Abstract
摘要
相似文献
1
Regarding: "Hydroxychloroquine: a comprehensive review and its controversial role in coronavirus disease 2019".关于：“羟氯喹：全面综述及其在2019冠状病毒病中的争议性作用”
Ann Med. 2021 Dec;53(1):286. doi: 10.1080/07853890.2021.1872094.
2
Insights into antiviral mechanisms of remdesivir, lopinavir/ritonavir and chloroquine/hydroxychloroquine affecting the new SARS-CoV-2.瑞德西韦、洛匹那韦/利托那韦和氯喹/羟氯喹影响新型 SARS-CoV-2 的抗病毒机制研究进展。
Biomed Pharmacother. 2020 Nov;131:110668. doi: 10.1016/j.biopha.2020.110668. Epub 2020 Aug 24.
3
SARS-CoV-2: Recent Reports on Antiviral Therapies Based on Lopinavir/Ritonavir, Darunavir/Umifenovir, Hydroxychloroquine, Remdesivir, Favipiravir and other Drugs for the Treatment of the New Coronavirus.SARS-CoV-2：洛匹那韦/利托那韦、达芦那韦/乌苯美司、羟氯喹、瑞德西韦、法匹拉韦等药物治疗新型冠状病毒的抗病毒治疗的最新报告。
Curr Med Chem. 2020;27(27):4536-4541. doi: 10.2174/0929867327666200416131117.
4
Chloroquine and Hydroxychloroquine in COVID-19: Practice Implications for Healthcare Professionals.氯喹和羟氯喹在2019冠状病毒病中的应用：对医疗保健专业人员的实践启示
J Coll Physicians Surg Pak. 2020 Oct;30(10):124-128. doi: 10.29271/jcpsp.2020.supp2.124.
5
Hydroxychloroquine and chloroquine in COVID-19: should they be used as standard therapy?羟氯喹和氯喹在 COVID-19 中的应用：它们是否应该作为标准疗法使用？
Clin Rheumatol. 2020 Aug;39(8):2461-2465. doi: 10.1007/s10067-020-05202-4. Epub 2020 Jun 3.
6
A pragmatic randomized controlled trial reports lack of efficacy of hydroxychloroquine on coronavirus disease 2019 viral kinetics.一项实用随机对照试验报告称羟氯喹对 2019 年冠状病毒病病毒动力学无效。
Nat Commun. 2020 Oct 20;11(1):5284. doi: 10.1038/s41467-020-19056-6.
7
Hydroxychloroquine as Postexposure Prophylaxis to Prevent Severe Acute Respiratory Syndrome Coronavirus 2 Infection : A Randomized Trial.羟氯喹作为暴露后预防严重急性呼吸综合征冠状病毒 2 感染的药物：一项随机试验。
Ann Intern Med. 2021 Mar;174(3):344-352. doi: 10.7326/M20-6519. Epub 2020 Dec 8.
8
Synergistic antiviral effect of hydroxychloroquine and azithromycin in combination against SARS-CoV-2: What molecular dynamics studies of virus-host interactions reveal.羟氯喹和阿奇霉素联合治疗 SARS-CoV-2 的协同抗病毒作用：病毒-宿主相互作用的分子动力学研究揭示了什么。
Int J Antimicrob Agents. 2020 Aug;56(2):106020. doi: 10.1016/j.ijantimicag.2020.106020. Epub 2020 May 13.
9
COVID-19 Pandemic - A Narrative Review of the Potential Roles of Chloroquine and Hydroxychloroquine.新型冠状病毒肺炎疫情：氯喹和羟氯喹潜在作用的叙事性综述。
Pain Physician. 2020 Aug;23(4S):S351-S366.
10
Connecting Hydroxychloroquine In Vitro Antiviral Activity to In Vivo Concentration for Prediction of Antiviral Effect: A Critical Step in Treating Patients With Coronavirus Disease 2019.将羟氯喹的体外抗病毒活性与体内浓度相关联，以预测其抗病毒效果：这是治疗 2019 年冠状病毒病患者的关键步骤。
Clin Infect Dis. 2020 Dec 15;71(12):3232-3236. doi: 10.1093/cid/ciaa623.
本文引用的文献
1
COVID-19 outpatients: early risk-stratified treatment with zinc plus low-dose hydroxychloroquine and azithromycin: a retrospective case series study.COVID-19 门诊患者：锌联合小剂量羟氯喹和阿奇霉素的早期风险分层治疗：一项回顾性病例系列研究。
Int J Antimicrob Agents. 2020 Dec;56(6):106214. doi: 10.1016/j.ijantimicag.2020.106214. Epub 2020 Oct 26.
2
Hydroxychloroquine: a comprehensive review and its controversial role in coronavirus disease 2019.羟氯喹：全面综述及其在 2019 冠状病毒病中的争议性作用。
Ann Med. 2021 Dec;53(1):117-134. doi: 10.1080/07853890.2020.1839959.
3
Cardiac Complications Attributed to Hydroxychloroquine: A Systematic Review of the Literature Pre-COVID-19.归因于羟氯喹的心脏并发症：COVID-19 之前的文献系统综述
Curr Cardiol Rev. 2021;17(3):319-327. doi: 10.2174/1573403X16666201014144022.
4
Hydroxychloroquine is effective, and consistently so when provided early, for COVID-19: a systematic review.羟氯喹对新冠病毒病有效，且早期使用时疗效持续：一项系统评价
New Microbes New Infect. 2020 Nov;38:100776. doi: 10.1016/j.nmni.2020.100776. Epub 2020 Oct 5.
5
Hydroxychloroquine is protective to the heart, not harmful: a systematic review.羟氯喹对心脏有保护作用，而非有害：一项系统评价。
New Microbes New Infect. 2020 Sep;37:100747. doi: 10.1016/j.nmni.2020.100747. Epub 2020 Aug 20.
6
Pathophysiological Basis and Rationale for Early Outpatient Treatment of SARS-CoV-2 (COVID-19) Infection.SARS-CoV-2（COVID-19）感染早期门诊治疗的病理生理基础和原理。
Am J Med. 2021 Jan;134(1):16-22. doi: 10.1016/j.amjmed.2020.07.003. Epub 2020 Aug 7.
7
Experience With Hydroxychloroquine and Azithromycin in the Coronavirus Disease 2019 Pandemic: Implications for QT Interval Monitoring.羟氯喹和阿奇霉素在 2019 冠状病毒病大流行中的应用经验：对 QT 间期监测的影响。
J Am Heart Assoc. 2020 Jun 16;9(12):e017144. doi: 10.1161/JAHA.120.017144. Epub 2020 May 28.
8
Effect of Chloroquine, Hydroxychloroquine, and Azithromycin on the Corrected QT Interval in Patients With SARS-CoV-2 Infection.氯喹、羟氯喹和阿奇霉素对 SARS-CoV-2 感染患者校正 QT 间期的影响。
Circ Arrhythm Electrophysiol. 2020 Jun;13(6):e008662. doi: 10.1161/CIRCEP.120.008662. Epub 2020 Apr 29.
9
Hydroxychloroquine neuromyotoxicity.羟氯喹的神经肌肉毒性。
J Rheumatol. 2000 Dec;27(12):2927-31.
Zotero 插件